{"id":"https://openalex.org/W7148967232","doi":"https://doi.org/10.1158/1538-7445.am2026-1132","title":"Abstract 1132: Malignant effusions for cfDNA/RNA genotyping and drug testing: Turning malignant fluids into personalized cancer models","display_name":"Abstract 1132: Malignant effusions for cfDNA/RNA genotyping and drug testing: Turning malignant fluids into personalized cancer models","publication_year":2026,"publication_date":"2026-04-03","ids":{"openalex":"https://openalex.org/W7148967232","doi":"https://doi.org/10.1158/1538-7445.am2026-1132"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2026-1132","doi":"https://doi.org/10.1158/1538-7445.am2026-1132","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2026-1132","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032923308","display_name":"Elba Mar\u00edn","orcid":"https://orcid.org/0000-0001-8882-7552","observed_orcids":["https://orcid.org/0000-0001-8882-7552"]},"institutions":[{"id":"https://openalex.org/I4210096255","display_name":"Hospital Universitario Dexeus","ror":"https://ror.org/00scfzf83","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210096255"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Elba Marin","raw_affiliation_strings":["1Pangaea Oncology, Hospital Universitari Dexeus, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Pangaea Oncology, Hospital Universitari Dexeus, Barcelona, Spain","institution_ids":["https://openalex.org/I4210096255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090598248","display_name":"Silvia Garc\u00eda-Rom\u00e1n","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096255","display_name":"Hospital Universitario Dexeus","ror":"https://ror.org/00scfzf83","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210096255"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Silvia Garcia-Roman","raw_affiliation_strings":["1Pangaea Oncology, Hospital Universitari Dexeus, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Pangaea Oncology, Hospital Universitari Dexeus, Barcelona, Spain","institution_ids":["https://openalex.org/I4210096255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108638674","display_name":"Cristina Aguado","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096255","display_name":"Hospital Universitario Dexeus","ror":"https://ror.org/00scfzf83","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210096255"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Cristina Aguado","raw_affiliation_strings":["1Pangaea Oncology, Hospital Universitari Dexeus, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Pangaea Oncology, Hospital Universitari Dexeus, Barcelona, Spain","institution_ids":["https://openalex.org/I4210096255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043180520","display_name":"M. Vives Usano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096255","display_name":"Hospital Universitario Dexeus","ror":"https://ror.org/00scfzf83","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210096255"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Marta Vives","raw_affiliation_strings":["1Pangaea Oncology, Hospital Universitari Dexeus, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Pangaea Oncology, Hospital Universitari Dexeus, Barcelona, Spain","institution_ids":["https://openalex.org/I4210096255"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Sonia Rodr\u00edguez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096255","display_name":"Hospital Universitario Dexeus","ror":"https://ror.org/00scfzf83","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210096255"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Sonia Rodr\u00edguez","raw_affiliation_strings":["1Pangaea Oncology, Hospital Universitari Dexeus, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Pangaea Oncology, Hospital Universitari Dexeus, Barcelona, Spain","institution_ids":["https://openalex.org/I4210096255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5146786464","display_name":"Susana Mu\u00f1oz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096255","display_name":"Hospital Universitario Dexeus","ror":"https://ror.org/00scfzf83","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210096255"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Susana Mu\u00f1oz","raw_affiliation_strings":["1Pangaea Oncology, Hospital Universitari Dexeus, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Pangaea Oncology, Hospital Universitari Dexeus, Barcelona, Spain","institution_ids":["https://openalex.org/I4210096255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015671073","display_name":"Noelia Armiger-Borr\u00e0s","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096255","display_name":"Hospital Universitario Dexeus","ror":"https://ror.org/00scfzf83","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210096255"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Noelia Armiger","raw_affiliation_strings":["1Pangaea Oncology, Hospital Universitari Dexeus, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Pangaea Oncology, Hospital Universitari Dexeus, Barcelona, Spain","institution_ids":["https://openalex.org/I4210096255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073547992","display_name":"A. Martinez Bueno","orcid":"https://orcid.org/0000-0002-5084-2746","observed_orcids":["https://orcid.org/0000-0002-5084-2746"]},"institutions":[{"id":"https://openalex.org/I4210095200","display_name":"Instituto Oncol\u00f3gico Dr. Rosell","ror":"https://ror.org/00r9kn296","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210095200"]},{"id":"https://openalex.org/I4210096255","display_name":"Hospital Universitario Dexeus","ror":"https://ror.org/00scfzf83","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210096255"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Alejandro Mart\u00ednez-Bueno","raw_affiliation_strings":["2Instituto Oncol\u00f3gico Dr. Rosell, Hospital Universitari Dexeus, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Instituto Oncol\u00f3gico Dr. Rosell, Hospital Universitari Dexeus, Barcelona, Spain","institution_ids":["https://openalex.org/I4210095200","https://openalex.org/I4210096255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072143967","display_name":"Mar\u00eda Gonz\u00e1lez\u2010Cao","orcid":"https://orcid.org/0000-0003-3791-540X","observed_orcids":["https://orcid.org/0000-0003-3791-540X"]},"institutions":[{"id":"https://openalex.org/I4210095200","display_name":"Instituto Oncol\u00f3gico Dr. Rosell","ror":"https://ror.org/00r9kn296","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210095200"]},{"id":"https://openalex.org/I4210096255","display_name":"Hospital Universitario Dexeus","ror":"https://ror.org/00scfzf83","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210096255"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Maria Gonzalez-Cao","raw_affiliation_strings":["2Instituto Oncol\u00f3gico Dr. Rosell, Hospital Universitari Dexeus, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Instituto Oncol\u00f3gico Dr. Rosell, Hospital Universitari Dexeus, Barcelona, Spain","institution_ids":["https://openalex.org/I4210095200","https://openalex.org/I4210096255"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ana Velasco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133944","display_name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Lleida","ror":"https://ror.org/03mfyme49","country_code":"ES","type":"facility","lineage":["https://openalex.org/I15766328","https://openalex.org/I4210133944","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ana Velasco","raw_affiliation_strings":["3Institut de Recerca Biom\u00e8dica de Lleida (IRBLleida), Lleida, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Institut de Recerca Biom\u00e8dica de Lleida (IRBLleida), Lleida, Spain","institution_ids":["https://openalex.org/I4210133944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5126273010","display_name":"Serafin Morales","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802050926","display_name":"Hospital Universitari Arnau de Vilanova","ror":"https://ror.org/01p3tpn79","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I2802050926","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Serafin Morales","raw_affiliation_strings":["4Hospital Universitari Arnau de Vilanova, Lleida, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Hospital Universitari Arnau de Vilanova, Lleida, Spain","institution_ids":["https://openalex.org/I2802050926"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132835332","display_name":"Reyes Roxana","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091801","display_name":"Hospital Quir\u00f3n Teknon","ror":"https://ror.org/00fsrkw38","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210091801"]},{"id":"https://openalex.org/I4210095200","display_name":"Instituto Oncol\u00f3gico Dr. Rosell","ror":"https://ror.org/00r9kn296","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210095200"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Reyes Roxana","raw_affiliation_strings":["5Instituto Oncol\u00f3gico Dr. Rosell, Hospital Teknon, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Instituto Oncol\u00f3gico Dr. Rosell, Hospital Teknon, Barcelona, Spain","institution_ids":["https://openalex.org/I4210091801","https://openalex.org/I4210095200"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082976167","display_name":"Ekaterina Meshoulam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095200","display_name":"Instituto Oncol\u00f3gico Dr. Rosell","ror":"https://ror.org/00r9kn296","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210095200"]},{"id":"https://openalex.org/I4210096255","display_name":"Hospital Universitario Dexeus","ror":"https://ror.org/00scfzf83","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210096255"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ekaterina Meshoulam","raw_affiliation_strings":["2Instituto Oncol\u00f3gico Dr. Rosell, Hospital Universitari Dexeus, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Instituto Oncol\u00f3gico Dr. Rosell, Hospital Universitari Dexeus, Barcelona, Spain","institution_ids":["https://openalex.org/I4210095200","https://openalex.org/I4210096255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008462749","display_name":"Andr\u00e9s Aguilar Aguilar","orcid":"https://orcid.org/0000-0003-1792-5643","observed_orcids":["https://orcid.org/0000-0003-1792-5643"]},"institutions":[{"id":"https://openalex.org/I4210095200","display_name":"Instituto Oncol\u00f3gico Dr. Rosell","ror":"https://ror.org/00r9kn296","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210095200"]},{"id":"https://openalex.org/I4210096255","display_name":"Hospital Universitario Dexeus","ror":"https://ror.org/00scfzf83","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210096255"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Andr\u00e9s Aguilar","raw_affiliation_strings":["2Instituto Oncol\u00f3gico Dr. Rosell, Hospital Universitari Dexeus, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Instituto Oncol\u00f3gico Dr. Rosell, Hospital Universitari Dexeus, Barcelona, Spain","institution_ids":["https://openalex.org/I4210095200","https://openalex.org/I4210096255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056891866","display_name":"Clara Mayo de las Casas","orcid":"https://orcid.org/0009-0007-4265-8248","observed_orcids":["https://orcid.org/0009-0007-4265-8248"]},"institutions":[{"id":"https://openalex.org/I4210096255","display_name":"Hospital Universitario Dexeus","ror":"https://ror.org/00scfzf83","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210096255"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Clara Mayo de las Casas","raw_affiliation_strings":["1Pangaea Oncology, Hospital Universitari Dexeus, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Pangaea Oncology, Hospital Universitari Dexeus, Barcelona, Spain","institution_ids":["https://openalex.org/I4210096255"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056676096","display_name":"Miguel \u00c1ngel Molina\u2010Vila","orcid":"https://orcid.org/0000-0001-8866-9881","observed_orcids":["https://orcid.org/0000-0001-8866-9881"]},"institutions":[{"id":"https://openalex.org/I4210096255","display_name":"Hospital Universitario Dexeus","ror":"https://ror.org/00scfzf83","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210096255"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Miguel \u00c1ngel Molina-Vila","raw_affiliation_strings":["1Pangaea Oncology, Hospital Universitari Dexeus, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Pangaea Oncology, Hospital Universitari Dexeus, Barcelona, Spain","institution_ids":["https://openalex.org/I4210096255"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"86","issue":"7_Supplement","first_page":"1132","last_page":"1132"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11356","display_name":"Pleural and Pulmonary Diseases","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/malignant-effusions","display_name":"malignant effusions","score":0.9890000224113464},{"id":"https://openalex.org/keywords/circulating-tumor-dna","display_name":"circulating tumor DNA","score":0.7599999904632568},{"id":"https://openalex.org/keywords/circulating-tumor-rna","display_name":"circulating tumor RNA","score":0.7440000176429749},{"id":"https://openalex.org/keywords/liquid-biopsy","display_name":"liquid biopsy","score":0.6880000233650208},{"id":"https://openalex.org/keywords/primary-tumor-cell-culture","display_name":"primary tumor cell culture","score":0.6949999928474426},{"id":"https://openalex.org/keywords/three-dimensional-tumor-models","display_name":"3D tumor models","score":0.8420000076293945},{"id":"https://openalex.org/keywords/drug-susceptibility-testing","display_name":"drug susceptibility testing","score":0.6169999837875366},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.5979999899864197},{"id":"https://openalex.org/keywords/molecular-diagnosis","display_name":"molecular diagnosis","score":0.34200000762939453},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.48100000619888306},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6549999713897705},{"id":"https://openalex.org/keywords/treatment-selection","display_name":"treatment selection","score":0.3580000102519989}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7214999794960022},{"id":"https://openalex.org/C31467283","wikidata":"https://www.wikidata.org/wiki/Q912147","display_name":"Genotyping","level":4,"score":0.567799985408783},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5494999885559082},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5428000092506409},{"id":"https://openalex.org/C61238886","wikidata":"https://www.wikidata.org/wiki/Q5121689","display_name":"Circulating tumor cell","level":4,"score":0.4708999991416931},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.46389999985694885},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.41940000653266907},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.4004000127315521},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.39320001006126404},{"id":"https://openalex.org/C2780283643","wikidata":"https://www.wikidata.org/wiki/Q2110267","display_name":"Primary tumor","level":4,"score":0.37279999256134033},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3668000102043152},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.34709998965263367},{"id":"https://openalex.org/C3018146709","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Anticancer drug","level":3,"score":0.34439998865127563},{"id":"https://openalex.org/C32220436","wikidata":"https://www.wikidata.org/wiki/Q2072214","display_name":"Personalized medicine","level":2,"score":0.3174000084400177},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3165999948978424},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.3050999939441681},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2870999872684479},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.2770000100135803},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2727000117301941},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.272599995136261},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.2639999985694885},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.25850000977516174},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.2515999972820282}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2026-1132","doi":"https://doi.org/10.1158/1538-7445.am2026-1132","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2026-1132","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7129504304","https://openalex.org/W4282927783","https://openalex.org/W2012570707","https://openalex.org/W4410809209","https://openalex.org/W2508806281","https://openalex.org/W2778123767","https://openalex.org/W4410814101","https://openalex.org/W3117488034","https://openalex.org/W7161588390","https://openalex.org/W3015380840"],"abstract_inverted_index":{"Abstract":[0],"Introduction":[1],"and":[2,10,72,106,110,122,146,159,194,199,204,262,352,369,380,400,407,416,425,472],"objectives:":[3],"Malignant":[4,467],"effusions":[5,349,468],"(MEs),":[6],"including":[7,296,367],"pleural,":[8],"ascitic":[9],"pericardiac":[11],"fluids,":[12],"occur":[13],"in":[14,61,66,76,118,175,187,196,293,325,363,396],"33%":[15],"of":[16,69,74,182,284,333,485],"patients":[17,126],"with":[18,83,127,133,219,335],"solids":[19],"tumors,":[20],"either":[21],"at":[22,25,255,260,301],"diagnosis":[23],"and/or":[24,222,299],"progression":[26],"to":[27,80,92,101,107,115,148,191,235,309],"therapy.":[28],"These":[29],"fluids":[30,477],"are":[31,38],"very":[32],"valuable":[33],"when":[34],"tumor":[35,58,172,210,247],"tissue":[36],"samples":[37,145,288,322],"inaccessible,":[39],"as":[40],"circulating":[41],"free":[42],"DNA/RNA":[43],"(cfDNA/RNA)":[44],"obtained":[45],"from":[46,57,125,136,142,244,286,307,343,347,412],"MEs":[47,94,124,177,243,391],"enable":[48],"accurate":[49],"molecular":[50],"diagnosis.":[51],"Primary":[52],"cultures":[53,212],"can":[54,392,409,422],"be":[55,116,340,384,393,410,423],"established":[56,208,342],"cells":[59,173,421],"present":[60],"MEs,":[62,345],"allowing":[63],"for":[64,402,418,469,489],"the":[65,84,97,176,183,227,266,397,413,486],"vitro":[67,197],"testing":[68],"antitumor":[70,426],"drugs":[71,427],"being":[73],"help":[75],"treatment":[77,378],"selection":[78],"due":[79],"their":[81],"similarity":[82],"patient\u2019s":[85],"tumor.":[86],"In":[87,170,206,272,372],"this":[88],"study,":[89],"we":[90],"aimed":[91],"incorporate":[93],"analysis":[95],"into":[96,478],"routine":[98],"clinical":[99,398],"practice":[100],"determine":[102],"clinically":[103,290],"relevant":[104,291],"alterations":[105,292],"establish":[108,192],"2D":[109,193],"3D":[111,195],"primary":[112,211],"culture":[113,189],"models":[114,481],"used":[117,401],"drug":[119,473],"testing.":[120],"Materials":[121],"methods:":[123],"solid":[128,246],"tumors":[129],"were":[130,178,217,233,253,315,361],"prospectively":[131],"collected,":[132],"volumes":[134],"ranging":[135,306],"5-5,000":[137],"mL.":[138],"cfDNA/RNA":[139,285,336,470],"was":[140,268,281,323],"extracted":[141],"all":[143],"fluid":[144,414],"subjected":[147],"genotyping":[149,471],"using":[150],"a":[151,160,330,387,403],"30-gene":[152],"DNA":[153],"next":[154],"generation":[155],"sequencing":[156],"(NGS)":[157],"panel":[158,164],"commercial":[161],"mRNA":[162,167],"nCounter":[163],"containing":[165],"770":[166],"hybridization":[168],"probes.":[169],"parallel,":[171],"contained":[174],"isolated":[179,411],"by":[180,202],"centrifugation":[181],"entire":[184],"volume,":[185],"cultured":[186,424],"complete":[188],"media":[190],"models,":[198],"molecularly":[200],"characterized":[201],"NGS":[203],"nCounter.":[205],"successfully":[207,341],"pure":[209],"(PTPC),":[213],"cell":[214],"viability":[215],"assays":[216,360],"performed":[218,362],"chemotherapeutic":[220],"agents":[221],"targeted":[223,370],"therapies":[224],"based":[225],"on":[226,270,319],"detected":[228],"alterations.":[229],"Clinical":[230],"follow-up":[231],"data":[232,277],"collected":[234,241,254,395],"evaluate":[236],"prognostic":[237],"associations.":[238],"Results":[239],"We":[240],"382":[242],"314":[245],"patients.":[248],"Of":[249],"them,":[250],"49.7%":[251],"(n=190)":[252],"therapy":[256],"progression,":[257],"28.3%":[258],"(n=108)":[259],"baseline":[261],"8.4%":[263],"(n=32)":[264],"while":[265,420],"patient":[267],"still":[269],"treatment.":[271],"13.6%":[273],"(n=52)":[274],"cases,":[275,328],"no":[276],"regarding":[278],"collection":[279],"time":[280],"available.":[282],"Genotyping":[283],"334":[287],"identified":[289],"77.3%":[294],"(n=258),":[295],"mutations,":[297],"amplifications,":[298],"fusions":[300],"variant":[302],"allele":[303],"frequencies":[304],"(VAF)":[305],"0.33":[308],"93%.":[310],"Among":[311],"these,":[312],"35.3%":[313],"(n=91)":[314],"considered":[316],"targetable.":[317],"Information":[318],"paired":[320],"cytology":[321],"available":[324],"11.6%":[326],"(n=93)":[327],"showing":[329,386],"concordance":[331],"rate":[332],"80%":[334],"genotyping.":[337],"PTPCs":[338,365],"could":[339,383],"61":[344],"mainly":[346],"pleural":[348],"(70.5%,":[350],"n=43)":[351],"lung":[353],"cancer":[354,480],"cases":[355,374],"(54.1%,":[356],"n=33).":[357],"Drug":[358],"sensitivity":[359,381],"47":[364],"(77%),":[366],"chemotherapy":[368],"therapies.":[371],"14":[373],"(29.7%)":[375],"correlation":[376],"between":[377],"received":[379],"results":[382],"analyzed,":[385],"93%":[388],"agreement.":[389],"Conclusions:":[390],"prospective":[394],"setting":[399],"dual":[404],"purpose.":[405],"cfDNA":[406],"cfRNA":[408],"fraction":[415],"employed":[417],"genotyping,":[419],"tested.":[428],"Citation":[429],"Format:":[430],"Elba":[431],"Marin,":[432],"Silvia":[433],"Garcia-Roman,":[434],"Cristina":[435],"Aguado,":[436],"Marta":[437],"Vives,":[438],"Sonia":[439],"Rodr\u00edguez,":[440],"Susana":[441],"Mu\u00f1oz,":[442],"Noelia":[443],"Armiger,":[444],"Alejandro":[445],"Mart\u00ednez-Bueno,":[446],"Maria":[447],"Gonzalez-Cao,":[448],"Ana":[449],"Velasco,":[450],"Serafin":[451],"Morales,":[452],"Reyes":[453],"Roxana,":[454],"Ekaterina":[455],"Meshoulam,":[456],"Andr\u00e9s":[457],"Aguilar,":[458],"Clara":[459],"Mayo":[460],"de":[461],"las":[462],"Casas,":[463],"Miguel":[464],"\u00c1ngel":[465],"Molina-Vila.":[466],"testing:":[474],"Turning":[475],"malignant":[476],"personalized":[479],"[abstract].":[482],"In:":[483],"Proceedings":[484],"American":[487],"Association":[488],"Cancer":[490,508],"Research":[491],"Annual":[492],"Meeting":[493],"2026;":[494],"Part":[495],"1":[496],"(Regular":[497],"Abstracts);":[498],"2026":[499],"Apr":[500],"17-22;":[501],"San":[502],"Diego,":[503],"CA.":[504],"Philadelphia":[505],"(PA):":[506],"AACR;":[507],"Res":[509],"2026;86(7":[510],"Suppl):Abstract":[511],"nr":[512],"1132.":[513]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2026-04-04T00:00:00"}